A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. - Nauck,M.A.; Duran,S.; Kim,D. (Diabetologia, 2007)